A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Vascular endothelial growth factor (VEGF)/ vascular endothelial growth factor receptor (VEGFR) inhibitors are agents that inhibit the activity of VEGF and VEGFR. VEGR and VEGFR (a tyrosine kinase receptor) signaling modulates angiogenesis, which involves making of new blood vessels from existing blood vessels.
Abnormal angiogenesis is known to occur in cancer, degenerative eye conditions and other conditions that involve inflammation. Specific monoclonal antibodies can be used as VEGF inhibitors and particular tyrosine kinase inhibitors are used as VEGFR inhibitors.
Vascular endothelial growth factor (VEGF)/ vascular endothelial growth factor receptor (VEGFR) inhibitors are used to treat various types of cancers.
See also
Medical conditions associated with VEGF/VEGFR inhibitors:
- Breast Cancer
- Breast Cancer, Metastatic
- Colorectal Cancer
- Gastrointestinal Stromal Tumor
- Glioblastoma Multiforme
- Hepatic Tumor
- Hepatocellular Carcinoma
- Macular Degeneration
- Malignant Glioma
- Neurofibromatosis
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Renal Cell Carcinoma
- Solid Tumors
- Thyroid Cancer
No comments:
Post a Comment